Welgen Inc. specializes in the production and purification of various viral vectors, including adenoviruses, lentiviruses, adeno-associated viruses (AAV), and retroviruses, catering to the needs of researchers in academic and pharmaceutical sectors. Their services encompass the amplification and purification of adenoviral stocks, which are achieved through advanced techniques such as centrifugation using cesium chloride gradients. Welgen also offers custom services for generating viral constructs based on client-provided sequences, ensuring high-quality products that are tested for sterility and titered spectrophotometrically. The company guarantees efficient silencing of gene expression through their shRNA selection and validation services, which are designed to achieve at least 70% silencing efficiency in co-transfection experiments.

In addition to viral vector production, Welgen provides a range of services for RNA interference (RNAi) and stable cell line generation, including the creation of lentivirus-generated stable cell lines and CRISPR knockin/knockout services. Their expertise extends to the generation of stable CHO cell lines and antibody-expressing cell lines, which are crucial for various biomedical research applications. By leveraging cutting-edge technologies and a commitment to quality, Welgen Inc. supports the advancement of research in gene therapy, vaccine development, and other biotechnological fields.

United States

Welgen Inc is a Biotechnology company located in 25 Winthrop St, Worcester, Massachusetts, United States.

Welgen Inc

Company Details